NCT03389724View on ClinicalTrials.gov

Prevention of Chemotherapy Induced Cardiotoxicity in Children With Bone Tumors and Acute Myeloid Leukemia

PHASE3CompletedINTERVENTIONAL

Enrollment

245

Participants

Timeline

Start Date

November 14, 2017

Primary Completion Date

November 1, 2021

Study Completion Date

November 1, 2021

Conditions

CardiotoxicityAcute Myeloid Leukemia in ChildrenBone Tumor

Interventions

DRUG

Capoten®

ACE-I (Capoten®) will be given to patients in the Intervention arm with the start of chemotherapy, twice daily at a dose of 0.5 mg/kg/day (divided over 2 doses)

Trial Locations (1)

Unknown

Children's Cancer Hospital Egypt 57357 Cairo, Egypt, Cairo

All Listed Sponsors

lead

Children's Cancer Hospital Egypt 57357

OTHER

NCT03389724 - Prevention of Chemotherapy Induced Cardiotoxicity in Children With Bone Tumors and Acute Myeloid Leukemia | Biotech Hunter | Biotech Hunter